Xiaozhi Yufa decoction ameliorates androgenetic alopecia through inhibition of MAPK signaling and regulation of lipid metabolism
Frontiers in Pharmacology · 27.11.2025 · 16
DOI: 10.3389/fphar.2025.1724224 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 27.11.2025. Verfasst von Yiyu Guo und 8 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Androgenetic alopecia represents the most common form of progressive hair loss, with current treatments showing limitations in efficacy or tolerability. Xiaozhi Yufa decoction (XZYFD), a Traditional Chinese Medicine formulation composed of 13 herbal medicines, has shown clinical potential in treating hair loss.
Methods
Network pharmacology analysis identified active compounds and potential targets of XZYFD, with molecular docking evaluating compound-target interactions. A testosterone propionate-induced mouse model was established to assess XZYFD’s therapeutic efficacy. Treatment effects were evaluated through hair regrowth assessment, histological examination, serum biochemical analysis, and molecular pathway investigation.
Results
Network pharmacology identified 57 overlapping targets between XZYFD and androgenetic alopecia, with enrichment in MAPK signaling and lipid metabolism pathways. In vivo experiments demonstrated that XZYFD dose-dependently promoted hair regrowth and restored follicular morphology. Treatment significantly improved hormonal profiles, reduced serum lipid levels, and suppressed inflammatory markers. XZYFD effectively inhibited androgen metabolism and suppressed activation of MAPK signaling and SREBP-1-mediated lipid metabolism pathways, as confirmed through gene expression, protein analysis, and immunohistochemistry.
Conclusion
XZYFD ameliorates androgenetic alopecia through simultaneous modulation of androgen metabolism, MAPK signaling, and SREBP-1-mediated lipid metabolism, with potential advantages for patients with metabolic dysfunction.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
- Kunming Municipal Hospital of Traditional Chinese Medicine, Kunming, Yunnan, China.
- The First Affiliated Hospital of Yunnan University of Chinese Medicine, Kunming, Yunnan, China.
Zitieren
APA
Guo, Y., Wu, J., Lu, Y., Qin, J., Huang, L., Zhang, F., Zhou, X., Yang, D., & Ye, J. (2025). Xiaozhi Yufa decoction ameliorates androgenetic alopecia through inhibition of MAPK signaling and regulation of lipid metabolism. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1724224
Vancouver
Guo Y, Wu J, Lu Y, Qin J, Huang L, Zhang F, et al. Xiaozhi Yufa decoction ameliorates androgenetic alopecia through inhibition of MAPK signaling and regulation of lipid metabolism. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1724224
BibTeX
@article{Guo2025,
author = {Guo, Yiyu and Wu, Jie and Lu, Yu and Qin, Jianping and Huang, Lanlan and Zhang, Fengrui and Zhou, Xiaomei and Yang, Dengke and Ye, Jianzhou},
title = {Xiaozhi Yufa decoction ameliorates androgenetic alopecia through inhibition of MAPK signaling and regulation of lipid metabolism},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {16},
doi = {10.3389/fphar.2025.1724224}
}
EUVIMED